Navigation

Insomnia - newer hypnotic drugs

Zaleplon, zolpidem and zopiclone for the management of insomnia

Status: History
Expected date of issue: April 2004
Process: MTA
Topic area:
  • Mental health and behavioural conditions
 

NICE project team

Executive Lead: Andrea Sutcliffe
Technical Lead: Dr Sarah Garner
Communications manager: Lucy Betterton
Project manager: Kathleen Dalby
Assessment Group / Evidence Review Group: Department of Pharmacology & Therapeutics, University of Liverpool
Top


 

Provisional schedule

Closing date for invited submissions / evidence submission: 20 May 2003
Final scope published: February 2003
1st appraisal committee meeting: 25 September 2003
2nd appraisal committee meeting: 26 November 2003
Top


 

Consultees and commentators

Consultees Commentators (no right of appeal)

Manufacturers / Sponsors

  • Aventis
  • Dominion
  • Generics
  • Lagap
  • Opus
  • Sanofi-Synthelabo
  • Wyeth

Patient / Carer Groups

  • British Association for Service to the Elderly
  • British Geriatrics Society
  • British Sleep Society
  • Council for Involuntary Tranquilliser Addiction
  • RoyalCollegeof General Practitioners
  • RoyalCollegeof Psychiatrists
  • Royal Pharmaceutical Society
  • Royal Society of Medicine, Sleep Medicine Section
  • Sleep Matters, Medical Advisory Service

Professional Groups

  • None

Others

  • Department of Health
  • Easington Primary Care Trust
  • KingstonPrimary Care Trust
  • Welsh Assembly Government

General

  • British National Formulary
  • National Collaborating Centre for Mental Health
  • National Collaborating Centre for Primary Care
  • NHS Confederation
  • NHS Information Authority
  • NHS Purchasing and Supplies Agency
  • NHS Quality Improvement Scotland
  • LoughboroughUniversitySleep Research Centre
  • Sleep Assessment and Advisory Service
  • Sleep Research Group, Section of Psychological Medicine, University of Glasgow

Comparator Manufacturers

  • None

Assessment Team

  • None

Associated Guideline Groups

  • None

Associated Public Health Groups

  • None

Research Groups

  • None

Top


 

Project history

Date Update
10 February 2003 List of Consultees added.
25 March 2003 Protocol added.
6 May 2003 Scope added.
Following discussion at the consultee information meeting on 27 March 2003 and subsequent communication with consultees it became clear that the focus of this appraisal would benefit from further clarity.
Consequently the title of the appraisal has been amended to 'zaleplon, zolpidem and zopiclone for the management of insomnia'. As the restriction to the management of short-term insomnia has been removed, the scope has been amended to clarify that the interventions will therefore be appraised according to their licensed indications in all categories of insomnia.
The assessment report protocol was also updated in the light of the amendment to the appraisal title and clarifications to the scope.
Top


 

Key documents

This page was last updated: 30 March 2010

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.